- Last edited on February 7, 2022
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | Previous revision | ||
|
cl:psychiatric-side-effects-of-medications [on February 5, 2019] |
cl:psychiatric-side-effects-of-medications [on April 17, 2019] |
||
|---|---|---|---|
| Line 3: | Line 3: | ||
| Medications and recreational substances can have profound psychiatric symptoms for patients. | Medications and recreational substances can have profound psychiatric symptoms for patients. | ||
| - | ==== Medications with Depression as a Side Effect ==== | + | == Medications with Depression as a Side Effect == |
| * [[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181628/|Tango, R. C. (2003). Psychiatric side effects of medications prescribed in internal medicine. Dialogues in clinical neuroscience, 5(2), 155.]] | * [[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181628/|Tango, R. C. (2003). Psychiatric side effects of medications prescribed in internal medicine. Dialogues in clinical neuroscience, 5(2), 155.]] | ||
| * [[https://jamanetwork.com/journals/jama/fullarticle/2684607|Qato, D. M., Ozenberger, K., & Olfson, M. (2018). Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States. JAMA, 319(22), 2289-2298.]] | * [[https://jamanetwork.com/journals/jama/fullarticle/2684607|Qato, D. M., Ozenberger, K., & Olfson, M. (2018). Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States. JAMA, 319(22), 2289-2298.]] | ||
| + | |||
| ===== Substance/Medication-Induced Major or Mild Neurocognitive Disorder ===== | ===== Substance/Medication-Induced Major or Mild Neurocognitive Disorder ===== | ||